Full Text | PDF

Share on facebook Share on tweeters Share on linkedin Share on googleplus

J Cancer 2011; 2:333-338. doi:10.7150/jca.2.333 This volume Cite

Review

Immunological Effects of Multikinase Inhibitors for Kidney Cancer: A Clue for Integration with Cellular Therapies?

Camillo Porta1,2 ✉, Chiara Paglino1,2, Ilaria Imarisio1,2, Carlo Ganini1, Paolo Pedrazzoli1

1. Oncologia Medica, Fondazione I.R.C.C.S. Policlinico San Matteo, Pavia, Italy.
2. Gruppo Italiano di Oncologia Nefrologica - G.I.O.N. (Italian Nephro-Oncology Group).

✉ Corresponding author: Camillo Porta, MD. Medical Oncology, I.R.C.C.S. San Matteo University Hospital Foundation, Piazzale C. Golgi, 19, I-27100 Pavia, Italy. Phone: +39-0382-501355 Fax: +39-0382-502442 E-mail: c.portapv.it

Citation:
Porta C, Paglino C, Imarisio I, Ganini C, Pedrazzoli P. Immunological Effects of Multikinase Inhibitors for Kidney Cancer: A Clue for Integration with Cellular Therapies?. J Cancer 2011; 2:333-338. doi:10.7150/jca.2.333. https://www.jcancer.org/v02p0333.htm
Other styles

File import instruction

Abstract

The multikinase inhibitors Sunitinib and Sorafenib not only inhibit angiogenesis and tumor growth, but also have the potential of interacting with the function of the immune system.

Presently available data seem to suggest that Sorafenib may exert immune suppressive effects, whilst the effects of Sunitinib are not so clear, being immune stimulatory in the vast majority - but not all - the studies reported.

Trials of combination of these multikinase inhibitors with different types of immune manipulation - and cellular therapies in particular - should be rationally designed taking into account all these complex effects, which ultimately deserve further insights.

Keywords: immunology, kidney cancer, multikinase inhibitors, cellular therapies.

Citation styles

APA
Porta, C., Paglino, C., Imarisio, I., Ganini, C., Pedrazzoli, P. (2011). Immunological Effects of Multikinase Inhibitors for Kidney Cancer: A Clue for Integration with Cellular Therapies?. Journal of Cancer, 2, 333-338. https://doi.org/10.7150/jca.2.333.

ACS
Porta, C.; Paglino, C.; Imarisio, I.; Ganini, C.; Pedrazzoli, P. Immunological Effects of Multikinase Inhibitors for Kidney Cancer: A Clue for Integration with Cellular Therapies?. J. Cancer 2011, 2, 333-338. DOI: 10.7150/jca.2.333.

NLM
Porta C, Paglino C, Imarisio I, Ganini C, Pedrazzoli P. Immunological Effects of Multikinase Inhibitors for Kidney Cancer: A Clue for Integration with Cellular Therapies?. J Cancer 2011; 2:333-338. doi:10.7150/jca.2.333. https://www.jcancer.org/v02p0333.htm

CSE
Porta C, Paglino C, Imarisio I, Ganini C, Pedrazzoli P. 2011. Immunological Effects of Multikinase Inhibitors for Kidney Cancer: A Clue for Integration with Cellular Therapies?. J Cancer. 2:333-338.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use